For research use only. Not for therapeutic Use.
Cefdinir Monohydrate(CAT: I024318) is a third-generation oral cephalosporin antibiotic with broad-spectrum activity against Gram-positive and Gram-negative bacteria. It functions by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. Cefdinir is particularly effective in treating respiratory tract infections, skin infections, and ear infections. Its monohydrate form enhances stability and solubility, improving its pharmacokinetic profile. Cefdinir Monohydrate is widely studied in infectious disease research and antibiotic development, providing valuable insights into combating antibiotic-resistant pathogens and optimizing antimicrobial therapies.
Catalog Number | I024318 |
CAS Number | 213978-34-8 |
Synonyms | Cefdinir monohydrate; UNII-6E7SN358SE |
Molecular Formula | C14H15N5O6S2 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate |
InChI | InChI=1S/C14H13N5O5S2.H2O/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6;/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23);1H2/b18-7-;/t8-,12-;/m1./s1 |
InChIKey | QWUVJQSNISEEQI-KYIYMPJCSA-N |
SMILES | C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\O)/C3=CSC(=N3)N)SC1)C(=O)O.O |